GSA Capital Partners LLP boosted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 389.5% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 65,044 shares of the pharmacy operator’s stock after acquiring an additional 51,756 shares during the quarter. Walgreens Boots Alliance accounts for 0.3% of GSA Capital Partners LLP’s portfolio, making the stock its 8th biggest holding. GSA Capital Partners LLP’s holdings in Walgreens Boots Alliance were worth $5,094,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Pathstone Family Office LLC raised its position in Walgreens Boots Alliance by 226.6% during the 2nd quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock valued at $1,969,000 after purchasing an additional 818 shares in the last quarter. Hudock Capital Group LLC raised its position in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares in the last quarter. Reilly Financial Advisors LLC raised its position in Walgreens Boots Alliance by 7.9% during the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after purchasing an additional 100 shares in the last quarter. Orrstown Financial Services Inc. raised its position in Walgreens Boots Alliance by 14.1% during the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock valued at $135,000 after purchasing an additional 213 shares in the last quarter. Finally, Founders Capital Management bought a new stake in Walgreens Boots Alliance during the 1st quarter valued at $161,000. Institutional investors own 63.58% of the company’s stock.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director John Anthony Lederer purchased 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The shares were purchased at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Corporate insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at $70.20 on Thursday. Walgreens Boots Alliance, Inc. has a 1 year low of $63.82 and a 1 year high of $88.00. The stock has a market capitalization of $71,264.06, a PE ratio of 13.84, a P/E/G ratio of 1.26 and a beta of 1.20. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. During the same period in the prior year, the company posted $1.07 EPS. The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. equities analysts predict that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.28%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.
Walgreens Boots Alliance announced that its board has authorized a stock buyback plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its shares are undervalued.
ILLEGAL ACTIVITY NOTICE: “GSA Capital Partners LLP Boosts Position in Walgreens Boots Alliance, Inc. (WBA)” was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://ledgergazette.com/2017/11/16/gsa-capital-partners-llp-boosts-position-in-walgreens-boots-alliance-inc-wba.html.
A number of equities research analysts have weighed in on the company. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, November 10th. Citigroup Inc. decreased their target price on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research report on Thursday, November 2nd. Leerink Swann lowered Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 1st. Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Monday, October 30th. Finally, Jefferies Group LLC set a $93.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Sunday, October 29th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $87.63.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.